One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    INDUSTRIAL AUTOMATION EQUIPMENT   >   Protein A Resin Market

プロテインAレジン市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2025年


[ 英語タイトル ] Protein A Resin Market by Product (Agarose-based, Glass/Silica-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), & End User - Global Forecast to 2025


Product Code : MNMIAE00112034
Survey : MarketsandMarkets
Publish On : April, 2021
Number of Pages : 136
Category : Industrial Automation Equipment
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide..
Growth in the market can primarily be attributed to factors such as demand for pre-packed disposable columns, increasing demand for therapeutic antibodies, and increasing pharmaceutical R&D spending
“The agarose-based protein A segment to hold the largest market share in 2020.”
Based on product, the protein A resin market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A. . In 2020, the agarose-based protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributed to the agarose being the most widely used matrix resin for the attachment of ligands that bind proteins.
“The recombinant protein A segment to hold the largest market share in 2020.”
Based on type, the protein A resin market is segmented into recombinant protein A and natural protein. In 2020, the recombinant protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributedto the frequent use of recombinant protein A resins during the production of monoclonal antibodies.

“The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020.”
Based on end user, the protein A resin market is segmented into pharmaceutical & biopharmaceutical companies, academic research institutes, and other end users. In 2020, the pharmaceutical and biopharmaceutical companiessegment is expected to command the largest share of the protein A resin market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.
“The Asia Pacific region to witness the highest growth during the forecast period.”
Geographically, North America dominated the global protein A resin market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increased R&D activities, as APAC has emerged as a key pharmaceutical and biopharmaceutical research hub. Considering this, a number of key pharmaceutical and biopharmaceutical companies have set up their research centers in the region. Also, local major players such as Ranbaxy, Dr. Reddy’s, Cipla, Lupin, and Cadila are actively involved in research on biosimilars and generic drugs.
Break of primary participants was as mentioned below:
 By Company Type: Tier I: 40%, Tier II: 30%, Tier III: 30%
 By Designation:C-Level Executives: 27%, Directors:18%, Others: 55%
 By Region:North America: 40%, Europe: 20%, Asia Pacific : 30%, Latin America: 8%, Middle-East: 2%
GE Healthcare(US), Repligen Corporation (US), and Merck Millipore (Germany)were the leading players in the protein A resin market.
Research Coverage
This report studies the protein A resin market based on product,type, application, end-user, and region. The report also studies the different factors (such as drivers, restraints,challenges, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the protein A resinmarket, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the protein A resin market and garner greater market shares.

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 INCLUSIONS AND EXCLUSIONS 20
1.3.1 MARKETS COVERED 21
FIGURE 1 PROTEIN A RESIN MARKET SEGMENTATION 21
1.3.2 YEARS CONSIDERED FOR THE REPORT 21
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
2.2 RESEARCH METHODOLOGY STEPS 23
FIGURE 2 RESEARCH METHODOLOGY: PROTEIN A RESIN MARKET 23
FIGURE 3 RESEARCH DESIGN 24
2.2.1 SECONDARY DATA 24
2.2.1.1 Key data from secondary sources 25
2.2.2 PRIMARY DATA 26
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 26
FIGURE 5 PRIMARY SOURCES 27
2.2.2.1 Key data from primary sources 27
2.3 MARKET SIZE ESTIMATION METHODOLOGY 28
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 28
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 29
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 30
FIGURE 8 DATA TRIANGULATION METHODOLOGY 30
2.5 ASSUMPTIONS FOR THE STUDY 31
2.6 COVID-19-SPECIFIC ASSUMPTIONS 31
3 EXECUTIVE SUMMARY 32
FIGURE 9 PROTEIN A RESIN MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 32
FIGURE 10 PROTEIN A RESIN MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 33
FIGURE 11 PROTEIN A RESIN MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 33
FIGURE 12 PROTEIN A RESIN MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 34
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE PROTEIN A RESIN MARKET 34

4 PREMIUM INSIGHTS 36
4.1 GLOBAL PROTEIN A RESIN MARKET OVERVIEW 36
FIGURE 14 ADVANTAGES OF PROTEIN A RESINS HAVE DRIVEN THEIR ADOPTION 36
4.2 NORTH AMERICA: PROTEIN A RESIN MARKET, 2019 37
FIGURE 15 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019 37
4.3 PROTEIN A RESIN MARKET, BY PRODUCT & SERVICE 37
FIGURE 16 AGAROSE-BASED PROTEIN A SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2020 37
4.4 PROTEIN A RESIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38
FIGURE 17 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
FIGURE 18 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 39
5.2.1 DRIVERS 39
5.2.1.1 Growing demand for disposable pre-packed columns 39
TABLE 1 ADVANTAGES OF PRE-PACKED COLUMNS 40
5.2.1.2 Increasing demand for therapeutic antibodies 40
5.2.1.3 Increasing pharmaceutical R&D spending 40
5.2.2 RESTRAINTS 41
5.2.2.1 High cost of resins 41
5.2.2.2 Dearth of skilled professionals 41
5.2.3 OPPORTUNITIES 41
5.2.3.1 Increasing number of CMOs and CROs 41
FIGURE 19 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET GROWTH,
2019–2024 42
5.2.3.2 Increasing demand for biosimilars 42
FIGURE 20 GROWTH OF THE BIOSIMILARS MARKET, 2018–2023 43
TABLE 2 LIST OF KEY BIOLOGICS UNDER THE THREAT OF PATENT EXPIRY 43
5.3 PRICING ANALYSIS: PROTEIN A RESIN MARKET 44
5.4 PORTER’S FIVE FORCES ANALYSIS 45
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS 45
5.4.1 THREAT OF SUBSTITUTES 46
5.4.2 BARGAINING POWER OF SUPPLIERS 46
5.4.3 BARGAINING POWER OF BUYERS 47
5.4.4 THREAT OF NEW ENTRANTS 47
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 48
5.5 IMPACT OF COVID-19 ON THE PROTEIN A RESIN MARKET 48

5.6 VALUE CHAIN ANALYSIS 49
FIGURE 22 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 49
5.6.1 RESEARCH & DEVELOPMENT 49
5.6.2 MANUFACTURING & ASSEMBLY 49
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 49
5.7 SUPPLY CHAIN ANALYSIS 50
5.7.1 PROMINENT COMPANIES 50
5.7.2 SMALL AND MEDIUM-SIZED ENTERPRISES 50
5.7.3 END USERS 50
FIGURE 23 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 50
FIGURE 24 ECOSYSTEM ANALYSIS OF THE PROTEIN A RESIN MARKET 51
6 PROTEIN A RESIN MARKET, BY PRODUCT 52
6.1 INTRODUCTION 53
TABLE 3 PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 53
6.2 AGAROSE-BASED PROTEIN A 53
6.2.1 BENEFITS OFFERED BY AGAROSE MAKES IT THE PREFERRED CHOICE FOR PROTEIN PURIFICATION 53
TABLE 4 AGAROSE-BASED PROTEIN A MARKET, BY REGION,
2018–2025 (USD MILLION) 54
TABLE 5 NORTH AMERICA: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 54
TABLE 6 EUROPE: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 54
TABLE 7 APAC: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 55
6.3 GLASS/SILICA-BASED PROTEIN A 55
6.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT THEIR MARKET GROWTH 55
TABLE 8 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION,
2018–2025 (USD MILLION) 55
TABLE 9 NORTH AMERICA: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 56
TABLE 10 EUROPE: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 56
TABLE 11 APAC: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 56
6.4 ORGANIC POLYMER-BASED PROTEIN A 57
6.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH 57
TABLE 12 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION,
2018–2025 (USD MILLION) 57
TABLE 13 NORTH AMERICA: ORGANIC POLYMER-BASED PROTEIN A MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 57
TABLE 14 EUROPE: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 15 APAC: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 58
7 PROTEIN A RESIN MARKET, BY TYPE 59
7.1 INTRODUCTION 60
TABLE 16 PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 60
7.2 RECOMBINANT PROTEIN A 60
7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH 60
TABLE 17 RECOMBINANT PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION) 60
TABLE 18 NORTH AMERICA: RECOMBINANT PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 61
TABLE 19 EUROPE: RECOMBINANT PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 61
TABLE 20 APAC: RECOMBINANT PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 61
7.3 NATURAL PROTEIN A 62
7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A HAVE RESTRICTED THE MARKET POTENTIAL OF NATURAL PROTEIN A 62
TABLE 21 NATURAL PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION) 62
TABLE 22 NORTH AMERICA: NATURAL PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 62
TABLE 23 EUROPE: NATURAL PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 63
TABLE 24 APAC: NATURAL PROTEIN A MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 63
8 PROTEIN A RESIN MARKET, BY APPLICATION 64
8.1 INTRODUCTION 65
TABLE 25 PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 65
8.2 ANTIBODY PURIFICATION 65
8.2.1 ANTIBODY PURIFICATION SEGMENT TO DOMINATE THE MARKET DURING
THE FORECAST PERIOD 65
TABLE 26 PROTEIN A RESIN MARKET FOR ANTIBODY PURIFICATION, BY REGION,
2018–2025 (USD MILLION) 66
8.3 IMMUNOPRECIPITATION 66
8.3.1 IMMUNOPRECIPITATION SEGMENT TO GROW AT A LOWER CAGR DURING
THE FORECAST PERIOD 66
TABLE 27 PROTEIN A RESIN MARKET FOR IMMUNOPRECIPITATION, BY REGION,
2018–2025 (USD MILLION) 66
9 PROTEIN A RESIN MARKET, BY END USER 67
9.1 INTRODUCTION 68
TABLE 28 PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION) 68
9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 68
9.2.1 PROTEIN A RESIN IS EXTENSIVELY USED TO PRODUCE BIOLOGICAL DRUGS 68
FIGURE 25 SPENDING ON BIOPHARMACEUTICAL RESEARCH,
2005–2020 (USD BILLION) 68
TABLE 29 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION) 69
9.3 ACADEMIC RESEARCH INSTITUTES 69
9.3.1 BOOMING R&D IN DRUG DISCOVERY LIKELY TO INCREASE THE USE OF PROTEIN A RESINS 69
TABLE 30 PROTEIN A RESIN MARKET FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2018–2025 (USD MILLION) 69
9.4 OTHER END USERS 70
TABLE 31 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION,
2018–2025 (USD MILLION) 70
10 PROTEIN A RESIN MARKET, BY REGION 71
10.1 INTRODUCTION 72
TABLE 32 PROTEIN A RESIN MARKET, BY REGION, 2018–2025 (USD MILLION) 72
10.2 NORTH AMERICA 73
FIGURE 26 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT 73
TABLE 33 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 73
TABLE 34 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 74
TABLE 35 NORTH AMERICA: PROTEIN A RESIN MARKET, BY TYPE,
2018–2025 (USD MILLION) 74
TABLE 36 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 74
TABLE 37 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 75
10.2.1 US 75
10.2.1.1 Booming R&D investment in the pharmaceutical industry to propel market growth 75
TABLE 38 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 75
TABLE 39 US: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 76
TABLE 40 US: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 76
TABLE 41 US: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION) 76
10.2.2 CANADA 76
10.2.2.1 Government initiatives focused on boosting the pharmaceutical industry to drive market growth 76
TABLE 42 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 77
TABLE 43 CANADA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 77
TABLE 44 CANADA: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 77
TABLE 45 CANADA: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 78

10.3 EUROPE 79
FIGURE 27 EUROPE: PROTEIN A RESIN MARKET SNAPSHOT 79
TABLE 46 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 80
TABLE 47 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 80
TABLE 48 EUROPE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 80
TABLE 49 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 81
TABLE 50 EUROPE: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 81
10.3.1 GERMANY 81
10.3.1.1 Flourishing biotechnology industry in the country to drive market growth 81
TABLE 51 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 82
TABLE 52 GERMANY: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 82
TABLE 53 GERMANY: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 82
TABLE 54 GERMANY: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 82
10.3.2 UK 83
10.3.2.1 Favorable R&D scenario in the country to support market growth 83
TABLE 55 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 83
TABLE 56 UK: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 83
TABLE 57 UK: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 83
TABLE 58 UK: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION) 84
10.3.3 FRANCE 84
10.3.3.1 Favorable healthcare scenario to boost market growth in France 84
TABLE 59 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 84
TABLE 60 FRANCE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 84
TABLE 61 FRANCE: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 85
TABLE 62 FRANCE: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 85
10.3.4 ITALY 85
10.3.4.1 Well-established pharmaceutical industry in the country to spur
the demand for protein A resins 85
TABLE 63 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 86
TABLE 64 ITALY: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 86
TABLE 65 ITALY: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 86
TABLE 66 ITALY: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION) 86

10.3.5 SPAIN 87
10.3.5.1 Presence of a large number of biotech R&D service providers to support market growth 87
TABLE 67 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 87
TABLE 68 SPAIN: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 87
TABLE 69 SPAIN: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 88
TABLE 70 SPAIN: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 88
10.3.6 REST OF EUROPE 88
TABLE 71 ROE: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 89
TABLE 72 ROE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 89
TABLE 73 ROE: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 89
TABLE 74 ROE: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION) 89
10.4 ASIA PACIFIC 90
FIGURE 28 APAC: PROTEIN A RESIN MARKET SNAPSHOT 90
TABLE 75 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 91
TABLE 76 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 91
TABLE 77 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY TYPE,
2018–2025 (USD MILLION) 91
TABLE 78 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 91
TABLE 79 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 92
10.4.1 JAPAN 92
10.4.1.1 Increasing demand for generic drugs and monoclonal antibody biosimilars is driving resin consumption in the country 92
TABLE 80 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 92
TABLE 81 JAPAN: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 82 JAPAN: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 93
TABLE 83 JAPAN: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 93
10.4.2 CHINA 93
10.4.2.1 Increased pharmaceutical R&D spending to drive market growth 93
TABLE 84 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 94
TABLE 85 CHINA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 94
TABLE 86 CHINA: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 94
TABLE 87 CHINA: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 95

10.4.3 INDIA 95
10.4.3.1 Growth of the pharma and biotech industries is leading to high demand for protein A resins in India 95
TABLE 88 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 95
TABLE 89 INDIA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 96
TABLE 90 INDIA: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 96
TABLE 91 INDIA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION) 96
10.4.4 REST OF ASIA PACIFIC 96
TABLE 92 ROAPAC: PROTEIN A RESIN MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 97
TABLE 93 ROAPAC: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 97
TABLE 94 ROAPAC: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 97
TABLE 95 ROAPAC: PROTEIN A RESIN MARKET, BY END USER,
2018–2025 (USD MILLION) 97
10.5 REST OF THE WORLD 98
FIGURE 29 ROW: PROTEIN A RESIN MARKET SNAPSHOT 98
TABLE 96 ROW: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 99
TABLE 97 ROW: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 99
TABLE 98 ROW: PROTEIN A RESIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 99
TABLE 99 ROW: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION) 99
11 COMPETITIVE LANDSCAPE 100
11.1 OVERVIEW 100
FIGURE 30 KEY DEVELOPMENTS IN THE PROTEIN A RESIN MARKET, 2017–2019 100
11.2 MARKET SHARE ANALYSIS 101
FIGURE 31 PROTEIN A RESIN MARKET SHARE ANALYSIS (2019) 101
11.3 COMPETITIVE LEADERSHIP MAPPING 102
11.3.1 VISIONARY LEADERS 102
11.3.2 INNOVATORS 102
11.3.3 DYNAMIC DIFFERENTIATORS 102
11.3.4 EMERGING COMPANIES 102
FIGURE 32 PROTEIN A RESIN MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 103
11.4 COMPETITIVE SCENARIO 104
11.4.1 PRODUCT LAUNCHES 104
TABLE 100 PRODUCT LAUNCHES (2017–2020) 104
11.4.2 FUNDING 104
TABLE 101 FUNDING (2017–2020) 104
11.4.3 ACQUISITIONS 104
TABLE 102 ACQUISITIONS (2017–2020) 104
11.4.4 PARTNERSHIPS 105
TABLE 103 PARTNERSHIPS (2017–2020) 105
12 COMPANY PROFILES 106
(Business overview, Products offered, Recent developments, MNM view)*
12.1 GE HEALTHCARE 106
FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT 106
12.2 MERCK MILLIPORE 108
FIGURE 34 MERCK MILLIPORE: COMPANY SNAPSHOT 108
12.3 REPLIGEN CORPORATION 110
FIGURE 35 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2019) 110
12.4 THERMO FISHER SCIENTIFIC, INC. 112
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 112
12.5 TOSOH BIOSCIENCE 114
FIGURE 37 TOSOH CORPORATION: COMPANY SNAPSHOT 114
12.6 PUROLITE CORPORATION 116
12.7 NOVASEP HOLDING SAS 117
12.8 AGILENT TECHNOLOGIES, INC. 118
FIGURE 38 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 118
12.9 GENSCRIPT BIOTECH CORPORATION 120
FIGURE 39 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2018) 120
12.10 PERKINELMER, INC. 122
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT 122
12.11 BIO-RAD LABORATORIES, INC. 123
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 123
12.12 OROCHEM 125
12.13 ANEKA CORPORATION 126
FIGURE 42 KANEKA CORPORATION: COMPANY SNAPSHOT 126
12.14 ABCAM PLC. 127
12.15 AGAROSE BEAD TECHNOLOGIES 128
12.16 AVANTOR, INC. 129
12.17 JSR LIFE SCIENCES 130
12.18 BIO-WORKS TECHNOLOGIES 131
12.19 TAKARA BIO 132
12.20 GENERON 133
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX 134
13.1 DISCUSSION GUIDE 134
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 137
13.3 AVAILABLE CUSTOMIZATIONS 139
13.4 RELATED REPORTS 139
13.5 AUTHOR DETAILS 140

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+